Unknown

Dataset Information

0

Aflibercept for treatment-naive diabetic macula oedema in a multi-ethnic population: Real-world outcomes from North West London.


ABSTRACT:

Purpose

To evaluate the clinical outcomes of patients with treatment-naïve diabetic macula oedema (DMO) treated with Aflibercept in routine clinic settings in ethnically diverse North West London (NWL) and compare to outcomes reported in the VIVID and VISTA clinical trials.

Methods

This was a retrospective multicentre interventional case series. Two hundred and seventy eyes of 221 treatment-naïve patients at three NWL hospitals initiated on Aflibercept and who had at least 12 months follow-up were included in the study. Visual acuity, central subfield thickness and macula volume were recorded at baseline, month 3, 6 and 12.

Results

There were significant differences between the NWL cohort and participants in the VIVID and VISTA trials at baseline including higher HbA1c and a higher proportion of eyes with proliferative diabetic retinopathy in the NWL cohort. The mean VA, mean CSFT and mean MV at baseline was 66.4 (± 14.6) letters, 417 (± 94) μm and 10.3 (± 1.9) mm3. The mean VA gain at 12 months was 4.0 (± 11.8) letters (p < 0.001); a total of 26% of eyes gained ≥ 10 letters, 15% of eyes gained ≥ 15 letters and 6% lost ≥15 letters. At 12-months, the mean reduction in CSFT was 108 (± 96) μm (p<0.001) and the mean reduction in MV was 1.05 (± 1.21) mm3 (p<0.001). An average of 6.2 (± 2.3) injections was given over 12 months. There was a significant association between functional and anatomical response category at 3 months and response category at 12 months (p<0.001).

Conclusion

The effectiveness of treatment with Aflibercept for patients in NWL was meaningfully lower than was reported in the VIVID and VISTA clinical trials. A high proportion of patients with good visual acuity at baseline, poorer glycaemic control, worse diabetic retinopathy and under-treatment likely contributed to lower functional and anatomical outcomes.

SUBMITTER: Dinah C 

PROVIDER: S-EPMC7877641 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8144175 | biostudies-literature
| S-EPMC4488481 | biostudies-literature
| S-EPMC8727562 | biostudies-literature
| S-EPMC10970839 | biostudies-literature
| S-EPMC8973508 | biostudies-literature
| S-EPMC7745011 | biostudies-literature
| S-EPMC7446656 | biostudies-literature
| S-EPMC3195760 | biostudies-literature
| S-EPMC7182551 | biostudies-literature
| S-EPMC8762127 | biostudies-literature